Literature DB >> 20521018

[Heart and kidneys].

D Kiski1, H Reinecke.   

Abstract

There is strong interaction between heart and kidneys in human beings. Both organs work together in many regulation mechanisms. Thus, heart failure leads in many cases to renal failure due to hemodynamic or hormonal feed-back mechanisms. Vice versa, chronic kidney disease turned out as a major and independent cardiovascular risk factor. Patients who suffer from both heart disease and chronic kidney disease are threatened from a very high morbidity and mortality. Moreover, the number of affected patients has doubled every 8-10 years--a dramatic trend which is ongoing. In many patients suffering from heart and chronic kidney disease, an under-use of cardiologic diagnostics as well as therapies has to be observed due to fears about adverse effects, which further enhances their worse prognosis.

Entities:  

Mesh:

Year:  2010        PMID: 20521018     DOI: 10.1007/s00108-009-2555-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  26 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Chronic kidney disease: common, harmful, and treatable--World Kidney Day 2007.

Authors:  Andrew S Levey; Sharon P Andreoli; Thomas DuBose; Robert Provenzano; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2007-01-17       Impact factor: 10.121

4.  The burden of chronic kidney disease.

Authors:  Rizwan A Hamer; A Meguid El Nahas
Journal:  BMJ       Date:  2006-03-11

Review 5.  The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis.

Authors:  Allan J Collins; Robert N Foley; David T Gilbertson; Shu-Chen Chen
Journal:  Clin J Am Soc Nephrol       Date:  2009-12       Impact factor: 8.237

6.  Myocardial revascularization in patients with end-stage renal disease: comparison of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting.

Authors:  K Ivens; F Gradaus; P Heering; F C Schoebel; M Klein; H D Schulte; B E Strauer; B Grabensee
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

7.  Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: insights from ARTS trial.

Authors:  Jiro Aoki; Andrew T L Ong; Angela Hoye; Lex A van Herwerden; J Eduardo Sousa; Adib Jatene; Johannes J R M Bonnier; Jacques P M A Schönberger; Nigel Buller; Robert Bonser; Wietze Lindeboom; Felix Unger; Patrick W Serruys
Journal:  Eur Heart J       Date:  2005-04-28       Impact factor: 29.983

Review 8.  Chronic kidney disease: the global challenge.

Authors:  A Meguid El Nahas; Aminu K Bello
Journal:  Lancet       Date:  2005 Jan 22-28       Impact factor: 79.321

9.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

10.  A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Authors:  Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto
Journal:  N Engl J Med       Date:  2009-10-30       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.